Literature DB >> 11181424

Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle.

A Choppin1, R M Eglen.   

Abstract

1. The pharmacological characteristics of muscarinic receptors mediating contraction of dog isolated ciliary muscle were determined and compared to those mediating contraction of dog urinary bladder smooth muscle. 2. (+)-Cis-dioxolane induced concentration-dependent contractions of ciliary muscle (pEC50=7.18+/-0.07, Emax=453+/-64 mg, n=19) and urinary bladder isolated smooth muscle (pEC50=6.55+/-0.07, Emax=11+/-1 g, n=19). These responses were antagonized by several muscarinic receptor antagonists (pKb values for the ciliary muscle and the bladder smooth muscle, respectively): atropine (8.25+/-0.14 and 9.21+/-0.09), pirenzepine (6.31+/-0.13 and 6.70+/-0.25), tolterodine (7.97+/-0.14 and 8.68+/-0.12), oxybutynin (7.40+/-0.08 and 7.88+/-0.12), zamifenacin (6.46+/-0.19 and 7.69+/-0.11), S-secoverine (6.66+/-0.14 and 8.13+/-0.07), AQ-RA 741 (6.16+/-0.15 and 7.08+/-0.23), p-F-HHSiD (7.10+/-0.27 and 7.35+/-0.07) and responses were not antagonized by PD 102807 (up to 100 nM). 3. In urinary bladder smooth muscle, the profile of antagonist pKB values correlated significantly with pK(i) values at human recombinant m3 muscarinic receptors, suggesting that M3 muscarinic receptors mediated the response. In the ciliary muscle, a significant (P<0.01) correlation was obtained with human recombinant m3 and m5 receptors. 4. Darifenacin displayed insurmountable antagonism at receptors in the bladder. At receptors in the ciliary muscle, it exhibited two phases of antagonism, comprising an initial low affinity (pKB<6) component and a high affinity phase (pKB>8). 5. The role of pigmentation in the atypical behaviour of darifenacin was examined. In blue coloured eyes, darifenacin produced apparent surmountable, competitive antagonism of the responses to (+)-cis-dioxolane (pKB=8.76+/-0.07). The antagonist profile obtained in this tissue suggested the involvement of a site which has the pharmacological attributes of the M5 receptor. 6. We suggest that the dog urinary bladder contracts in response to M3 muscarinic receptor activation. Contraction of the brown-eyed dog ciliary muscle is more complex and may include involvement of at least two receptors, possibly the M5 and M3 receptor, whereas blue-eyed dog ciliary muscle may involve a single population of M5 muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181424      PMCID: PMC1572633          DOI: 10.1038/sj.bjp.0703901

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Ocular effects of antimuscarinic compounds: is clinical effect determined by binding affinity for muscarinic receptors or melanin pigment?

Authors:  E J German; D Wood; M A Hurst
Journal:  J Ocul Pharmacol Ther       Date:  1999-06       Impact factor: 2.671

Review 2.  The muscarinic M(5) receptor: a silent or emerging subtype?

Authors:  R M Eglen; S R Nahorski
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug.

Authors:  H Doods; M Entzeroth; N Mayer
Journal:  Eur J Pharmacol       Date:  1991-01-03       Impact factor: 4.432

4.  M3-muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary processes.

Authors:  R E Honkanen; E F Howard; A A Abdel-Latif
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-03-01       Impact factor: 4.799

5.  Reexamination of the structure of eumelanin.

Authors:  S Ito
Journal:  Biochim Biophys Acta       Date:  1986-08-06

6.  Muscarinic receptors of rabbit irides.

Authors:  C Akesson; C Swanson; P N Patil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

7.  A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter.

Authors:  I T Bognar; U Altes; C Beinhauer; I Kessler; H Fuder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

8.  Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle.

Authors:  H Fuder; J Schöpf; J Unckell; M T Wesner; C Melchiorre; R Tacke; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

9.  Iris pigmentation and atropine mydriasis.

Authors:  M Salazar; K Shimada; P N Patil
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  8 in total

1.  M(3) muscarinic receptors mediate contraction of human urinary bladder.

Authors:  Charlotte Fetscher; Marina Fleichman; Martina Schmidt; Susanne Krege; Martin C Michel
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 2.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 3.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

4.  Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder: differential regulation of M2 and M3 receptors?

Authors:  Christian Kories; Claudia Czyborra; Charlotte Fetscher; Tim Schneider; Susanne Krege; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-28       Impact factor: 3.000

5.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 6.  A benefit-risk assessment of extended-release oxybutynin.

Authors:  Martin C Michel
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Acetylcholine induces Ca2+ oscillations via m3/m4 muscarinic receptors in the mouse oocyte.

Authors:  Dawon Kang; Jae-Yong Park; Jaehee Han; In-Ha Bae; Sook-Young Yoon; Sang Soo Kang; Wan Sung Choi; Seong-Geun Hong
Journal:  Pflugers Arch       Date:  2003-10-14       Impact factor: 3.657

8.  Effects of pirenzepine on pupil size and accommodation in rhesus monkeys.

Authors:  Lisa A Ostrin; Laura J Frishman; Adrian Glasser
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.